$439 Million is the total value of Endurant Capital Management LP's 53 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 106.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRput | $73,812,000 | – | 25,300 | +100.0% | 16.81% | – |
| New | INVACARE CORPnote 5.000%11/1 | $51,196,000 | – | 56,727,000 | +100.0% | 11.66% | – | |
| New | TRILLIUM THERAPEUTICS INCcall | $36,314,000 | – | 206,800 | +100.0% | 8.27% | – | |
| ABBV | Buy | ABBVIE INC | $19,463,000 | +102.1% | 180,429 | +111.0% | 4.43% | +67.4% |
| HUM | Buy | HUMANA INC | $17,131,000 | +145.0% | 44,022 | +178.8% | 3.90% | +103.1% |
| JNJ | Buy | JOHNSON & JOHNSON | $15,839,000 | +191.4% | 98,077 | +197.2% | 3.61% | +141.4% |
| HOLX | Buy | HOLOGIC INC | $14,771,000 | +99.7% | 200,119 | +80.5% | 3.36% | +65.6% |
| BIO | Buy | BIO RAD LABS INCcl a | $13,630,000 | +79.0% | 18,272 | +54.6% | 3.10% | +48.3% |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $12,533,000 | +85.6% | 211,821 | +109.6% | 2.85% | +53.8% |
| SIBN | Buy | SI-BONE INC | $10,093,000 | +698.5% | 471,214 | +1073.5% | 2.30% | +562.2% |
| VCYT | Buy | VERACYTE INC | $7,813,000 | +39.4% | 168,211 | +20.0% | 1.78% | +15.4% |
| AZYO | Buy | AZIYO BIOLOGICS INC | $6,625,000 | -21.0% | 952,610 | +9.1% | 1.51% | -34.6% |
| AVTR | Buy | AVANTOR INC | $6,624,000 | +22.4% | 161,963 | +6.3% | 1.51% | +1.4% |
| MCK | New | MCKESSON CORP | $6,490,000 | – | 32,551 | +100.0% | 1.48% | – |
| OMI | Buy | OWENS & MINOR INC NEW | $6,376,000 | +124.8% | 203,784 | +204.2% | 1.45% | +86.4% |
| New | INVACARE CORPnote 5.000%11/1 | $6,207,000 | – | 7,000,000 | +100.0% | 1.41% | – | |
| ATR | New | APTARGROUP INC | $6,110,000 | – | 51,191 | +100.0% | 1.39% | – |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $6,104,000 | -24.6% | 610,401 | +6.9% | 1.39% | -37.5% |
| AHCO | New | ADAPTHEALTH CORP | $4,539,000 | – | 194,886 | +100.0% | 1.03% | – |
| SELB | Buy | SELECTA BIOSCIENCES INC | $4,249,000 | +9.7% | 1,021,501 | +10.2% | 0.97% | -9.1% |
| ALBO | Buy | ALBIREO PHARMA INC | $3,661,000 | +0.5% | 117,328 | +13.3% | 0.83% | -16.7% |
| PKI | New | PERKINELMER INC | $3,338,000 | – | 19,264 | +100.0% | 0.76% | – |
| BDX | New | BECTON DICKINSON & CO | $2,723,000 | – | 11,077 | +100.0% | 0.62% | – |
| SNY | New | SANOFIsponsored adr | $2,643,000 | – | 54,821 | +100.0% | 0.60% | – |
| RGLS | Buy | REGULUS THERAPEUTICS INC | $2,450,000 | +15.6% | 3,547,208 | +36.0% | 0.56% | -4.3% |
| AXSM | New | AXSOME THERAPEUTICS INC | $1,716,000 | – | 52,048 | +100.0% | 0.39% | – |
| IMUX | Buy | IMMUNIC INC | $1,641,000 | -24.4% | 185,448 | +4.7% | 0.37% | -37.4% |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $1,464,000 | – | 29,838 | +100.0% | 0.33% | – |
| KRYS | New | KRYSTAL BIOTECH INC | $1,198,000 | – | 22,938 | +100.0% | 0.27% | – |
| BOLT | New | BOLT BIOTHERAPEUTICS INC | $1,139,000 | – | 90,041 | +100.0% | 0.26% | – |
| ALVR | New | ALLOVIR INC | $1,113,000 | – | 44,430 | +100.0% | 0.25% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $959,000 | – | 62,743 | +100.0% | 0.22% | – |
| PDCO | New | PATTERSON COS INC | $808,000 | – | 26,799 | +100.0% | 0.18% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.